Cadila Healthcare Shares Plunge After FDA Warning
Cadila Healthcare Ltd has received a U.S. Food and Drug Administration (FDA) warning letter for violating manufacturing standards at two of its production facilities, the latest in a series of Indian companies to face such action.
Cadila shares plunged as much as 17 percent to their lowest intraday level since March in Mumbai on Thursday and closed down about 15 percent.
Cadila shares plunged as much as 17 percent to their lowest intraday level since March in Mumbai on Thursday and closed down about 15 percent.